estriol has been researched along with Communicable Diseases in 3 studies
hormonin: estrogen replacement; each tablet contains 600 ug micronized 17beta-estradiol, 270 ug estriol and 1.4 mg estrone
chlorapatite : A phosphate mineral with the formula Ca5(PO4)3Cl.
Communicable Diseases: An illness caused by an infectious agent or its toxins that occurs through the direct or indirect transmission of the infectious agent or its products from an infected individual or via an animal, vector or the inanimate environment to a susceptible animal or human host.
| Excerpt | Relevance | Reference |
|---|---|---|
| "03 mg estriol-lactobacilli combination on the vaginal ecosystem in postmenopausal breast cancer (BC) survivors on aromatase inhibitors (AI) with severe atrophic vaginitis." | 7.81 | Effect of ultra-low-dose estriol and lactobacilli vaginal tablets (Gynoflor®) on inflammatory and infectious markers of the vaginal ecosystem in postmenopausal women with breast cancer on aromatase inhibitors. ( Bellen, G; Buchholz, S; Donders, G; Grob, P; Neven, P; Ortmann, O; Prasauskas, V, 2015) |
| "03 mg estriol-lactobacilli combination on the vaginal ecosystem in postmenopausal breast cancer (BC) survivors on aromatase inhibitors (AI) with severe atrophic vaginitis." | 3.81 | Effect of ultra-low-dose estriol and lactobacilli vaginal tablets (Gynoflor®) on inflammatory and infectious markers of the vaginal ecosystem in postmenopausal women with breast cancer on aromatase inhibitors. ( Bellen, G; Buchholz, S; Donders, G; Grob, P; Neven, P; Ortmann, O; Prasauskas, V, 2015) |
| "To evaluate the effectiveness of live lactobacilli in combination with low dose oestriol for restoration of the vaginal flora after anti-infective treatment." | 2.71 | The effectiveness of live lactobacilli in combination with low dose oestriol (Gynoflor) to restore the vaginal flora after treatment of vaginal infections. ( Grob, P; Kaiser, R; Ozkinay, E; Terek, MC; Tuncay, G; Yayci, M, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Donders, G | 1 |
| Bellen, G | 1 |
| Neven, P | 1 |
| Grob, P | 2 |
| Prasauskas, V | 1 |
| Buchholz, S | 1 |
| Ortmann, O | 1 |
| Ozkinay, E | 1 |
| Terek, MC | 1 |
| Yayci, M | 1 |
| Kaiser, R | 1 |
| Tuncay, G | 1 |
| Tikkanen, MJ | 1 |
| Adlercreutz, H | 1 |
1 trial available for estriol and Communicable Diseases
| Article | Year |
|---|---|
The effectiveness of live lactobacilli in combination with low dose oestriol (Gynoflor) to restore the vaginal flora after treatment of vaginal infections.
Topics: Administration, Intravaginal; Adolescent; Adult; Aged; Anti-Infective Agents; Combined Modality Ther | 2005 |
2 other studies available for estriol and Communicable Diseases
| Article | Year |
|---|---|
Effect of ultra-low-dose estriol and lactobacilli vaginal tablets (Gynoflor®) on inflammatory and infectious markers of the vaginal ecosystem in postmenopausal women with breast cancer on aromatase inhibitors.
Topics: Administration, Intravaginal; Adult; Aromatase Inhibitors; Biomarkers; Breast Neoplasms; Candida; Ca | 2015 |
Recurrent jaundice in pregnancy. 3. Quantitative determination of urinary estriol conjugates, including studies in pruritus gravidarum.
Topics: Chromatography; Chromatography, Gel; Communicable Diseases; Estriol; Female; Glucuronates; Humans; H | 1973 |